Consistent with the diverse incidence of brain metastasis among breast cancers subtypes (36–38), most specimens collected for implantation originated from TN and HER2+ tumors, and 6 of 8 established BM-PDXs were from TN and ER−HER2+ subtypes. The gene discussed is ERBB2; the disease is breast carcinoma.